July 23, 2024
A Maryland federal judge on Tuesday again tossed a False Claims Act suit accusing an Allergan unit of overcharging Medicaid, previously revived by the U.S. Supreme Court, saying a whistleblower still hadn't shown any deliberate wrongdoing by the company.
May 17, 2024
Allergan drew a Maryland federal court's attention to the Centers for Medicare & Medicaid Services' abandonment of a regulation clarifying drug pricing, arguing the move undermined a whistleblower's claims that it overcharged Medicaid by over $680 million.
December 12, 2023
A whistleblower defended her claim that Allergan overcharged Medicaid by more than $680 million, saying her lawsuit clearly shows that senior managers knew of their alleged wrongdoing in line with the U.S. Supreme Court's standard for finding liability.